28 February 2023 in Bulletin of Russian State Medical University
Due to the changes in the modern world, it is necessary to develop the domestic pharmaceutical industry, which is a task especially important in the context of implementation of the import substitution policy. The article classifies the main measures the state industrial policy has for the pharmaceutical industry; these measures cover informational and consulting aspects, research and technical parts, innovations and economic matters. Practical actions and their possible consequences are considered for each group of the industrial policy measures: encouragement of domestic consumption, regulation of imports, stimulation and support of exports, stimulation of technological development, public-private partnerships, support of the development of intersectoral territorial production complexes (clusters), direct state support of investment activities, tax incentives for investors.
20 April 2026 in Journal of Modern Competition
The article is devoted to the study of the features of antitrust regulation of the pharmaceutical industry under sanctions restrictions. Unlike existing approaches, the authors consider the interaction of exogenous factors (sanctions) and endogenous regulatory mechanisms (antitrust legislation) as a unified system requiring comprehensive analysis. An empirical analysis of statistical data for the period 2022–2024 on pharmaceutical drugs with patent protection expiring in 2024–2026 is conducted. The methods used include structural analysis of market segments, price dynamics analysis, and concentration assessment by distribution channels. The necessity of adapting traditional methods of antitrust control to the specifics of pharmaceutical markets functioning under external restrictions is substantiated. The author draws attention to the formation of asymmetric competition conditions, where market access is determined not only by economic but also by geopolitical factors. Data on the dominance of government distribution channels (hospitals and preferential programs account for more than 55% of the market in terms of sales) and significant volatility of the main indicators of the industry (10.6% decline in sales in 2023 followed by 25.8% growth in 2024) are provided. Differentiated impact of sanctions on various market segments is revealed, particularly critical reduction in high-cost nosologies volumes. Average price growth in certain segments up to 39% is noted. The obtained results confirm the conclusions of previous studies about the need for comprehensive industry stimulation, while simultaneously revealing new aspects of the interaction between sanctions restrictions and competitive environment. It is noted that traditional market concentration indicators may not reflect the real competitive situation under new conditions, requiring the development of adapted antitrust analysis methods.